6g8i
From Proteopedia
(Difference between revisions)
m (Protected "6g8i" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==14-3-3sigma in complex with a R124beta3R mutated YAP pS127 phosphopeptide== | |
| - | + | <StructureSection load='6g8i' size='340' side='right'caption='[[6g8i]], [[Resolution|resolution]] 1.60Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6g8i]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6G8I OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6G8I FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene></td></tr> | |
| - | [[Category: | + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=TSA:8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC+ACID'>TSA</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6g8i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6g8i OCA], [http://pdbe.org/6g8i PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6g8i RCSB], [http://www.ebi.ac.uk/pdbsum/6g8i PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6g8i ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/1433S_HUMAN 1433S_HUMAN]] Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. When bound to KRT17, regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway (By similarity). p53-regulated inhibitor of G2/M progression. | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Andrei, S A]] | ||
| + | [[Category: Brunsveld, L]] | ||
| + | [[Category: Milroy, L G]] | ||
| + | [[Category: Ottmann, C]] | ||
| + | [[Category: Thijssen, V]] | ||
| + | [[Category: Beta amino acid hippo pathway yap/taz]] | ||
| + | [[Category: Oncoprotein]] | ||
Revision as of 05:56, 17 April 2019
14-3-3sigma in complex with a R124beta3R mutated YAP pS127 phosphopeptide
| |||||||||||
